Chronic Diseases
PhaSER secures $2.7m Gates Foundation renewal for neglected disease drug research
November 14, 2026Chagas disease, Chronic Diseases, Gates Foundation, Infections and infestations, Pharmacy, Rare Diseases, TB, malaria, neglected disease, preclinical studies
Scottish drug development company PhaSER Biomedical has secured a US$2.7m (£2m), two-year grant renewal from the Gates Foundation to support …
Qureight paper argues for fibrosis extent as imaging biomarker in lung disease trials
November 11, 2026Chronic Diseases, HRCT, biomarkers, idiopathic pulmonary fibrosis, respiratory illness
Qureight has published a peer-reviewed paper arguing that the extent of pulmonary fibrosis should be considered the principal structural imaging …
The evidence bar impacting UK medical cannabis access
November 6, 2026Cannabinoids, Chronic Diseases, Legislation, NICE, Pharmacy, chronic pain, drug approval
By Mike Morgan-Giles Private prescribing of cannabis-based medicines in the UK has more than doubled in a year. Getting the …
Five Facts about medicinal cannabis and chronic pain
November 4, 2026Medical Communications Chronic Diseases, Five Facts, Pain, Smoking Cessation, chronic disease, medicinal cannabis
1 Chronic pain is generally defined as pain that persists or recurs for more than three months. It can arise …
East London pharmacies pilot cholesterol-lowering injections to cut waiting times
October 29, 2026Cardiology, Chronic Diseases, Hospital Management, NICE, cardiology, cholesterol, community healthcare, pharmacies
A pilot scheme in east London is offering cholesterol-lowering injections at community pharmacies to help patients access treatment sooner and …
Sobi’s olezarsen recommended for EU approval in severe hypertriglyceridaemia
October 27, 2026Chronic Diseases, EMA, Pain, Pharmacy, drug development, regulatory
Sobi’s olezarsen (TRYNGOLZA) has received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for Human Use …
How will biomarker-led diagnostics reshape respiratory medicine?
October 11, 2026Asthma & COPD, COPD, Chronic Diseases, Diagnostics, biomarkers, clinical trial
By Dr Louise Ryan Murphy, Chronic obstructive pulmonary disease (COPD) is typically diagnosed and assessed through symptoms, lung function and …
“That gap between innovation and delivery was what stood out to me most”
October 11, 2026Drug Delivery Systems, Drug Safety, Marketing, Medical Communications, Regulatory Affairs AI governance, Asthma & COPD, Chronic Diseases, Devices, Diagnostics, Hospital Management, NHS, drug delivery, healthcare solutions, pharmaceutical technology
Pharmafile chats with Camunda’s Natosha McNeal about the vital role of delivery, onboarding AI and putting the patient at the …
Fortysomethings’ non-attendance at NHS Health Checks raises concerns, says study
October 11, 2026Chronic Diseases, NHS, Oncology, cardiovascular disease, survey
People in their forties account for almost three-quarters of those who do not attend NHS Health Checks, highlighting the challenge …
Excellence in Healthcare Partnership Awards – A Collaborative Working Project Between Sanofi and The University Hospital Birmingham Severe Asthma Team
October 11, 2026Data Management, Medical Communications, Medical Education, Patient Awareness Programmes, Quality Assurance, Training Asthma & COPD, Chronic Diseases, EHP Awards, HCPs, Sanofi
Launched in February 2026 by PMGroup Worldwide Ltd and Visions4Health, the Excellence in Healthcare Partnerships (EHP) Awards recognise outstanding collaborations …
Clinical trials don’t just have a recruitment problem, they have an enrolment protection problem.
September 5, 2026Clinical & Scientific, Clinical Research, Clinical Trial Services, Clinical research Training, Clinical trial specialist packaging, Data Capture Asthma & COPD, Chronic Diseases, Immunology, Rare Diseases, Sample integrity, clinical trials, enrolment
By Dr. Richard Graham Industry conversations about clinical trial participation tend to focus on awareness, access, and willingness to enrol. …
EpiEndo publishes new data supporting glasmacinal’s potential in COPD
June 13, 2025Medical Communications, Research and Development Chronic Diseases, EpiEndo Pharmaceuticals, Fraunhofer Institute for Toxicology and Experimental Medicine, antimicrobial resistance, chronic obstructive pulmonary disease (COPD), lung disease
EpiEndo Pharmaceuticals has announced the publication of three peer-reviewed articles in Pulmonary Pharmacology and Therapeutics, highlighting the therapeutic potential of …
Digital platform for hypertension management launches in Europe
June 13, 2025Business Services, Technical Consultancy Chronic Diseases, HealthTech, Newel Health, digital platform, high blood pressure, hypertension management, hypertension therapy
Newel Health, a European healthtech company specialising in digital medical devices, has announced that Amicomed, its digital platform for hypertension …
GRI Bio announces two global patents granted for Europe and Japan
April 2, 2025Research and Development Chronic Diseases, GRI Bio, autoimmune diseases, biotech, fibrotic diseases, inflammatory diseases, patent
GRI Bio, a biotech company that specialises in treatment for inflammatory, fibrotic and autoimmune diseases, has announced that two global …
Dupixent approved as first biologic medicine in Japan for COPD patients
April 2, 2025Research and Development COPD, Chronic Diseases, Regeneron, Sanofi, biotech, respiratory disease
The Ministry of Health, Labour and Welfare in Japan has authorised marketing and manufacturing of Dupixent (dupilumab) for the treatment …
Latest content
Recruitment experts hired in search for new CGT Catapult chief
Envirogen secures place on NHS Scotland reverse osmosis framework
